Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvenon in Progressive Supranuclear Palsy
NCT01537549Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Sep 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, acetyl-l-carnitine in progressive supranuclear palsy (PSP), sponsored by Weill Cornell Medicine. Started Sep 2010; status: completed.
02
Drugs
alpha-lipoic acidacetyl-l-carnitine
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT01537549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537549.